Related Experiment Video
Updated: Jan 8, 2026

Light-driven Enzymatic Decarboxylation
Published on: May 22, 2016
Structure-guided engineering of P450BM3 as a cofactor-free peroxygenase for efficient biotransformation of cresol
Yadan Yang1, Xiangmin Meng2, Di Yan1
1State Key Laboratory of Mariculture Biobreeding and Sustainable Goods, Yellow Sea Fisheries Research Institute, Chinese Academy of Fishery Sciences, Qingdao 266071, China; College of Biological Engineering, Shandong Provincial Key Laboratory of Biochemical Engineering, Qingdao University of Science and Technology, Qingdao 266042, China.
Abstract:
Cresols, widely used industrial intermediates and common constituents of wastewater, are of environmental concern due to their acute toxicity and frequent occurrence. In this study, we engineered cytochrome P450BM3 to operate as a cofactor-free peroxygenase directly driven by H2O2. Introduction of an aspartic acid residue at position 268 (T268D) endowed the enzyme with enhanced peroxidase activity, while additional substitutions at positions 78, 87, and 328 reshaped the active site to improve substrate binding and stabilization. The resulting quadruple mutant V78F/F87A/T268D/A328F exhibited rapid and nearly complete biotransformation of o-, m-, and p-cresol within 2 min under mild conditions (25 °C, pH 7.0), achieving catalytic efficiencies of 56000, 48333, and 57464 M-1 s-1, respectively. The enzyme maintained >98 % activity in simulated wastewater, highlighting its robustness in complex matrices. UPLC-MS analysis confirmed that cresol conversion mainly proceeds through hydroxylation and oxidation pathways rather than mineralization. Structural analysis revealed that the synergistic arrangement of residues at positions 78, 87, 268, and 328 enhanced H2O2 activation and facilitated π-π interactions with aromatic substrates. These results establish a robust and generalizable platform for peroxygenase-based biotransformation of phenolic pollutants, offering a sustainable and efficient strategy for wastewater treatment.
More Related Videos
10:14Expression and Purification of Nuclease-Free Oxygen Scavenger Protocatechuate 3,4-Dioxygenase
Published on: November 8, 2019
09:33Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
Published on: March 20, 2018
Related Concept Videos
Drug Metabolism: Phase I Reactions
Peroxisomes
Bioremediation
Reduction of Alkenes: Asymmetric Catalytic Hydrogenation
The metal catalyst used can be either heterogeneous or homogeneous. When hydrogenation of an alkene generates a chiral center, a pair of enantiomeric products is expected to form. However, an enantiomeric excess of one of the products can be facilitated using an enantioselective reaction or an...
Drug Biotransformation: Overview
Phase I Oxidative Reactions: Overview